Clinical Trial Update: Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLC [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating whether minimal residual disease can guide adjuvant therapy in stage I non-small cell lung cancer. The t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Guangdong Association of Clinical Trials | Conditions: Non-Small Cell Lung Cancer | NA | Status: NOT_YET_RECRUITING